Kai van Hateren
Impact in
- Transplantation top 10%
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antifungal resistance and susceptibility 5
- HIV/AIDS drug development and treatment 3
- Tuberculosis Research and Epidemiology 2
- Antimicrobial Resistance in Staphylococcus 2
-
- Antibiotics Pharmacokinetics and Efficacy 8
- Co-authors
- Jan‐Willem C. Alffenaar (16 shared papers)Ben Greijdanus (7 shared papers)Jos G. W. Kosterink (9 shared papers)Donald R. A. Uges (4 shared papers)Daan Johannes Touw (14 shared papers)Remco A. Koster (5 shared papers)Tjip S. van der Werf (6 shared papers)Mireille A. Wessels (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Journal of Chromatography B (3 papers)Bioanalysis (3 papers)Therapeutic Drug Monitoring (1 paper)Biomedical Chromatography (1 paper)
- Partner nations
- NetherlandsAustraliaColombia
In The Last Decade
Kai van Hateren
21 papers receiving 443 citations
Peers
Comparison fields: 5 of 71
- Transplantation 27
- Pharmacology 153
- Infectious Diseases 166
- Immunology 90
- Clinical Biochemistry 28
Countries citing papers authored by Kai van Hateren
This map shows the geographic impact of Kai van Hateren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai van Hateren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai van Hateren more than expected).
Fields of papers citing papers by Kai van Hateren
This network shows the impact of papers produced by Kai van Hateren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai van Hateren. The network helps show where Kai van Hateren may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai van Hateren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 94 | |
| 2 | 2013 | 55 | |
| 3 | 2019 | 55 | |
| 4 | 2014 | 40 | |
| 5 | 2017 | 32 | |
| 6 | 2015 | 31 | |
| 7 | 2013 | 28 | |
| 8 | 2017 | 25 | |
| 9 | 2013 | 15 | |
| 10 | 2017 | 14 | |
| 11 | 2019 | 12 | |
| 12 | 2014 | 10 | |
| 13 | 2018 | 9 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 6 | |
| 16 | 2023 | 6 | |
| 17 | 2015 | 5 | |
| 18 | 2018 | 5 | |
| 19 | 2018 | 3 | |
| 20 | 2018 | 3 |
About Kai van Hateren
Kai van Hateren is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Transplantation and Immunology, having authored 21 papers that have together received 458 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antifungal resistance and susceptibility (5 papers), Biosimilars and Bioanalytical Methods (4 papers), HIV/AIDS drug development and treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Tuberculosis Research and Epidemiology (2 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Transplantation (27 citations), Pharmacology (153 citations), Infectious Diseases (166 citations), Immunology (90 citations) and Clinical Biochemistry (28 citations). Kai van Hateren has collaborated with scholars based in Netherlands, Australia and Colombia. Frequent co-authors include Jan‐Willem C. Alffenaar, Ben Greijdanus, Jos G. W. Kosterink, Donald R. A. Uges, Daan Johannes Touw, Remco A. Koster, Tjip S. van der Werf, Mireille A. Wessels, Marieke G. G. Sturkenboom and Kim C. M. van der Elst. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Chromatography B, Bioanalysis, Therapeutic Drug Monitoring and Biomedical Chromatography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.